Making the biotech IPO work

Nature Biotechnology

Volumn 31, Issue 11, 2013, Pages 969-970

  McNamee, Laura ^a   Ledley, Fred ^a  

^a BENTLEY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; BIOTECHNOLOGY; CONSUMER; DRUG INDUSTRY; HUMAN; INVESTMENT; LETTER; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; THEORY;

BIOTECHNOLOGY; INDUSTRY; PUBLIC SECTOR;

EID: 84887493756     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2711     Document Type: Letter

References (9)

1. Foster, R.N. Innovation: The Attacker's Advantage (Summit Books, New York; 1986).
2. C hristensen, C.M. & Raynor, M.E. The Innovator's Solution: Creating and Sustaining Successful Growth (Harvard Business School Press, Boston; 2003).
3. McNamee, L.M. & Ledley, F.D. Nat. Biotechnol. 30, 937-943 (2012).
4. DiMasi, J.A., Feldman, L., Seckler, A. & Wilson, A. Clin. Pharmacol. Ther. 87, 272-277 (2010).
5. Gschwind, A., Fischer, O.M. & Ullrich, A. Nat. Rev. Cancer 4, 361-370 (2004).
6. Sheridan, C. Nat. Biotechnol. 29, 121-128 (2011).
7. C ockburn, I.H.R. Proc. Natl. Acad. Sci. USA 93, 12725-12730 (1996).
8. Pisano, G.P. Science Business: the Promise, the Reality, and the Future of Biotech (Harvard Business School Press, Boston; 2006).
9. Guedj, I. & Scharfstein, D. Organizational Scope and Investment: Evidence from the Drug Development Strategies of Biopharmaceutical Firms. NBER working paper 10933 (National Bureau of Economic Research, 2004).